On April 20, we have announced a strategic distribution agreement with Anasac, one of Chile’s leading agricultural input companies with more than 78 years of market presence.
Under this agreement, NURSPRAY®HC will be commercialized in Chile, initially targeting cherries, table grapes, and apples, with plans to progressively expand to additional specialty crops. The partnership supports Fyteko’s international expansion strategy and reinforces Anasac’s commitment to innovative, science based biological solutions.
Strong validation in Chilean production systems
Extensive multi location field evaluations conducted in 2024 and 2025 across Chile confirmed the consistent performance of NURSPRAY®HC in fruit production systems, particularly in cherries, table grapes, and apples.
These trials validated its positioning as a pre harvest solution, improving fruit condition, aligning with the quality requirements of export driven fruit markets.
A strategic long term partnership
For Fyteko, this collaboration represents a key milestone in strengthening its footprint in Latin America through a trusted local partner with strong technical expertise and proximity to growers. For Anasac, it enriches its biological portfolio with a scientifically differentiated technology based on a single, well-defined active molecule with a clear mode of action.
Image Legend: Field trials testing NURSPRAY®HC in table grapes improved post harvest fruit quality, supporting export driven market requirements.
“Anasac shares our vision of bringing scientifically robust and clearly differentiated biological solutions to growers,” said Guillaume Wegria, CEO and Co-founder of Fyteko. “This long term agreement reflects both the strength of the field data generated in Chile and Anasac’s strategic commitment to innovation in specialty crops.”
“NURSPRAY®HC represents a new class of plant solutions based on defined signaling molecules,” added Gabriel Ormeño, Anasac CEO. “Its consistent performance and clear mode of action make it a strong fit for our specialty crop portfolio and long term biological strategy.”
Read the full Press Release on Agropages